Thoracic Outlet Syndrome Market Research Report Information: By Type (Neurogenic, Venous, Arterial Thoracic Outlet Syndrome) Diagnosis (Ct Scan, Mri Scan, Blood Tests, Arteriogram), Treatment (Surgery, Medication), End-User- Forecast Till 2027
ID: MRFR/MED/4100-HCR | February 2021 | Region: Global | 85 Pages
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Thoracic Outlet Syndrome Market, By Type
6.1 Introduction
6.2 Neurogenic Thoracic Outlet Syndrome
6.2.1 Market Estimates & Forecast, 2020 – 2027
6.3 Venous Thoracic Outlet Syndrome
6.3.1 Market Estimates & Forecast, 2020 – 2027
6.4 Arterial Thoracic Outlet Syndrome
6.4.1 Market Estimates & Forecast, 2020 – 2027
Chapter 7. Global Thoracic Outlet Syndrome Market, By Diagnosis
7.1 Introduction
7.2 Nerve Conduction Studies
7.2.1 Market Estimates & Forecast, 2020 – 2027
7.3 Vascular Studies
7.3.1 Market Estimates & Forecast, 2020 – 2027
7.4 Chest X-Ray
7.4.1 Market Estimates & Forecast, 2020 – 2027
7.5 Computed Tomography (CT) Scan
7.5.1 Market Estimates & Forecast, 2020 – 2027
7.6 Magnetic Resonance Imaging (MRI)
7.6.1 Market Estimates & Forecast, 2020 – 2027
7.7 Magnetic Resonance Imaging With Angiography (MRA)
7.7.1 Market Estimates & Forecast, 2020 – 2027
7.8 Arteriogram/Venogram
7.8.1 Market Estimates & Forecast, 2020 – 2027
7.9 Blood Tests
7.9.1 Market Estimates & Forecast, 2020 – 2027 Chapter 8. Global Thoracic Outlet Syndrome Market, By Treatment
8.1 Introduction
8.2 Surgery
8.2.1 Market Estimates & Forecast, 2018 – 2023
8.3 Medications
8.3.1 Market Estimates & Forecast, 2018 – 2023
8.4 Physical Therapy
8.4.1 Market Estimates & Forecast, 2018 – 2023
8.5 Others
8.5.1 Market Estimates & Forecast, 2018 – 2023 Chapter 9. Global Thoracic Outlet Syndrome Market, By End User
9.1 Introduction
9.2 Hospital & Clinics
9.2.1 Market Estimates & Forecast, 2020 – 2027
9.3 Diagnostic Centers
9.3.2 Market Estimates & Forecast, 2020 – 2027
9.4 Academic And Research Institutes
9.4.1 Market Estimates & Forecast, 2020 – 2027
9.5 Others
9.5.2 Market Estimates & Forecast, 2020 – 2027
Chapter 10. Global Thoracic Outlet Syndrome Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest Of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic Of Korea
10.4.6 Rest Of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest Of The Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Types Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Bayer AG
11.2.1 Company Overview
11.2.2 Types Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Boehringer Ingelheim
11.3.1 Company Overview
11.3.2 Types Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Johnson & Johnson Services, Inc.
11.4.1 Company Overview
11.4.2 Types/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Sanofi
11.5.1 Company Overview
11.5.2 Types Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.6 Vertical Pharmaceuticals LLC
11.6.1 Company Overview
11.6.2 Types Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 DAIICHI SANKYO
11.7.1 Overview
11.7.2 Types Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Prediction Of Thoracic Outlet Syndrome Industry
Chapter 13 Appendix LIST OF TABLES
Table 1 Thoracic Outlet Syndrome Industry Synopsis, 2020 – 2027
Table 2 Thoracic Outlet Syndrome Market Estimates And Forecast, 2020 – 2027, (USD Million)
Table 3 Thoracic Outlet Syndrome Market By Region, 2020 – 2027, (USD Million)
Table 4 Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 5 Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 6 Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 7 Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 8 North America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 9 North America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 10 North America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 11 North America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 12 US Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 13 US Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 14 US Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 15 US Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 16 Canada Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 17 Canada Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 18 Canada Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 19 Canada Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 20 South America Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 21 South America Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 22 South America Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 23 South America Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 24 Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 25 Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 26 Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 27 Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 28 Western Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 29 Western Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 30 Western Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 31 Western Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 32 Eastern Europe Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 33 Eastern Europe Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 34 Eastern Europe Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 35 Eastern Europe Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 36 Asia Pacific Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 37 Asia Pacific Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 38 Asia Pacific Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 39 Asia Pacific Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
Table 40 Middle East & Africa Thoracic Outlet Syndrome Market By Type, 2020 – 2027, (USD Million)
Table 41 Middle East & Africa Thoracic Outlet Syndrome Market By Diagnosis, 2020 – 2027, (USD Million)
Table 42 Middle East & Africa Thoracic Outlet Syndrome Market By Treatment, 2020 – 2027, (USD Million)
Table 43 Middle East & Africa Thoracic Outlet Syndrome Market By End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES Figure 1 Research Process
Figure 2 Segmentation For Thoracic Outlet Syndrome Market
Figure 3 Segmentation Market Dynamics For Thoracic Outlet Syndrome Market
Figure 4 Global Thoracic Outlet Syndrome Market Share, By Type 2020
Figure 5 Global Thoracic Outlet Syndrome Market Share, By Diagnosis 2020
Figure 6 Global Thoracic Outlet Syndrome Market Share, By Treatment 2020
Figure 7 Global Thoracic Outlet Syndrome Market Share, By End Users, 2020
Figure 8 Global Thoracic Outlet Syndrome Market Share, By Region, 2020
Figure 9 North America Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 10 Europe Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 11 Asia Pacific Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 12 Middle East & Africa Thoracic Outlet Syndrome Market Share, By Country, 2020
Figure 13 Global Thoracic Outlet Syndrome Market: Company Share Analysis, 2020 (%)
Figure 14 Abbott Laboratories: Key Financials
Figure 15 Abbott Laboratories Segmental Revenue
Figure 16 Abbott Laboratories: Geographical Revenue
Figure 17 Bayer AG: Key Financials
Figure 18 Bayer AG: Segmental Revenue
Figure 19 Bayer AG: Geographical Revenue
Figure 20 Boehringer Ingelheim: Key Financials
Figure 21 Boehringer Ingelheim: Segmental Revenue
Figure 22 Boehringer Ingelheim: Geographical Revenue
Figure 23 Johnson & Johnson Services, Inc.: Key Financials
Figure 24 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 25 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 26 Sanofi: Key Financials
Figure 27 Sanofi: Segmental Revenue
Figure 28 Sanofi Geographical Revenue
Figure 29 Vertical Pharmaceuticals LLC: Key Financials
Figure 30 Vertical Pharmaceuticals LLC: Segmental Revenue
Figure 31 Vertical Pharmaceuticals LLC: Geographical Revenue
Figure 32 DAIICHI SANKYO: Key Financials
Figure 33 DAIICHI SANKYO: Segmental Revenue
Figure 34 DAIICHI SANKYO: Geographical Revenue
Bottom of Form
Speak to Analyst
Request a Free Sample
Thoracic Outlet Syndrome Market Overview
The thoracic outlet syndrome market size is expected to grow at a CAGR of 7% within the forecast period globally. A thoracic outlet syndrome is a group of disorders that cause pain in the shoulder, neck, and arms, numbness, and creeping sensation of the fingers. The thoracic outlet is the space between the collar bone and the first rib. The thoracic outlet syndrome is caused due to the compression of the blood vessel in the thoracic outlet. The injuries caused because of the sports-related problem, anatomical defects, tumors in the chest, damage in the shoulder or neck, and obesity are the common causes of thoracic outlet syndrome. The three types of thoracic outlet syndromes are neurogenic, vascular, and non-specific. Treatment of thoracic outlet syndrome market includes therapeutic drugs such as anti-inflammatory drugs, muscle relaxants, and anti-coagulation drugs. When medicine therapy does not improve the condition of thoracic outlet syndrome, surgical treatments are performed to cure them. Neurogenic thoracic outlet syndrome is most common, i.e., it adds up around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome adds up around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of cases. This provides a clear picture of Thoracic Outlet Syndrome Market Outlook.
Covid-19 analysis
The covid-19 outbreak has affected the majority of the world’s population resulting in a worldwide economic downfall, which resulted in a global recession. The thoracic outlet syndrome treatment market has been damaged in a variety of ways; as the covid cases increased rapidly, it had a detrimental impact on the thoracic outlet syndrome treatment market. Merchants feel pressurized to prioritize their business by replacing required goods. Thoracic outlet syndrome treatment market remained closed as the restriction for global shutdown tightened. When the markets return to a normal pace in a number of countries, supply chain issues emerge.
Chief Factors Existing In The Market
- Key Market Drivers
Rise in commonness of lung injuries, lung tumors, congestive heart failure, and lymph or blood vessel blockage. According to the World health organization, lungs are very vulnerable to infection and injury from the external environment of constant exposure of particles, chemicals, and infectious organisms in the open air. At least 2 million people are exposed to toxic smoke of biomass fuel globally, which is burned inefficiently in poorly ventilated indoor stoves or fireplaces. The most common lethal neoplasm globally is lung cancer, which is responsible for around 1.6 million deaths each year and still counting. According to the world heart federation, the commonness of heart failure is increasing globally to an estimated number of 26 million. The second driving feature is a rise in the commonness of pleural effusion. This Dyspnea is the most common symptom of pleural effusion. Pleural effusion is a highly common disease among all pleural diseases and affects almost a 1.5million people in the U.S each year.
- Market Challenges
The high cost related to the treatment is the major drawback for the thoracic outlet syndrome treatment market share, and the lack of infrastructure in low-income countries will hamper the thoracic outlet syndrome treatment market growth rate. The complications involved with thoracic outlet syndrome will hamper the thoracic outlet syndrome market value. Many people are not ready to get a complicated procedure treatment, which is the biggest challenge for the market.
- Market Opportunities
The thoracic outlet syndrome market is owing to a huge patient pool which can be a perk for the market as more people are getting treated; it helps in the rise of economic growth globally. The proper development of healthcare technology results in more people interested in treatment can provide great scope to the thoracic outlet syndrome market.
Of course, when the healthcare technology gets developed, there will be a rise in healthcare expenditure which provides scope to the market.
- Market Restraints
Less awareness about thoracic outlet syndrome will further restrain the thoracic outlet syndrome market forecast period. Less knowledge about the treatment makes the market vulnerable to lose. Lack of trained and skilled professionals is also a restraining factor of the thoracic outlet syndrome market.
Cumulative Evaluation Of The Market
Several changes seen in the market can be assessed later for a better understanding of the market strategy. The thoracic outlet syndrome is significantly growing due to the accidents taking place across the world. Chest injuries where collar bone and ribs get severely impacted give rise to the thoracic syndrome. Some other anatomical defects can be considered as well as to understand the growth for this market as well.
Market Segmentation
The thoracic outlet syndrome market is divided on the basis of type, diagnosis, treatment, and end-user.
- Under the basis of type, the market Thoracic Outlet Syndrome Market is divided into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
- Under the basis of diagnosis, the market is divided into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, magnetic resonance imaging, computed tomography scan, and magnetic resonance imaging with angiography, arteriogram/venogram, and blood tests.
- Under the basis of treatment, the market is divided into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxants, thrombolytic medications, anticoagulant medications, and others.
- Under the basis of end-user, the market is divided into hospitals & clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.
Regional Analysis
According to the Thoracic Outlet Syndrome Market Analysis, the Americas dominate the thoracic outlet syndrome market due to increased awareness among the people and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention, out of the total annual healthcare expenditure, 86% is for the population with chronic health conditions in from the United States.
Europe has the second rank in the thoracic outlet syndrome market. It is expected that the support provided by government bodies for research & development and improvement in the repaying policies in healthcare will operate the market in Europe.
The Asia Pacific is the fastest growing in the thoracic outlet syndrome market, owing to a huge patient pool, development of healthcare technology, and rising healthcare expenditure in some countries within the region. In the years 2015 to 2016, according to the Australian Institute of Health and Welfare, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure in 2014–15.
The Middle East & Africa has the lowest rank in the market for thoracic outlet syndrome due to lack of technical knowledge, unskilled professional, less awareness and poor medical facilities.
Competitive Intensity Within The Industry
Thoracic outlet syndrome market provides a detailed competitive landscape about the competitors. The detail includes company overview, company financials, market potential, revenue generated, investment in research and development, new market initiatives, revenue generated global presence, production sites and facilities, clinical trials pipelines, product approvals, patents, product width and breadth, company strengths and weaknesses, product launch, application dominance, technology lifeline curve.
Some of the major key players operating in the thoracic outlet syndrome market trends are Piramal Critical Care, Pfizer Inc., Validus Pharmaceuticals LLC, GlaxoSmithKline plc, Novartis AG, Sanofi, Abbott, Bristol-Myers Squibb Company, Bayer AG, F. Hoffmann-La Roche Ltd., Mallinckrodt, Johnson & Johnson Private Limited, Endo International plc, Boehringer Ingelheim International GmbH., Apotex Inc., Mylan N.V., Allergan, Takeda Pharmaceutical Company Limited., Oriental Pharma, and DAIICHI SANKYO COMPANY, LIMITED and others.
Recent Market Developments
The thoracic outlet syndrome market developed advanced technology for the treatment, hired skilled professionals, increased the revenue for the treatment; after post covid, the growth of this market has increased. Some of the regions that we're unaware of the disease are now aware of the disease and its treatment.
Report Overview
This report contains the market overview, covid-19 analysis and how it affects the market, the key drivers, the market opportunities, the key drivers, the challenges that the market face, the market restraints, the market segmentation, the regional analysis, market outlook, the competitive landscape, report overview and recent development of the market.
Key Industrial Segments
By Type
- Neurogenic
- Venous
- Arterial Thoracic Outlet Syndrome
Diagnosis
- CT Scan
- Mri Scan
- Blood Tests
- Arteriogram
By Treatment
- Non-steroidal Anti-Inflammatory Drugs (NSAID)
- Skeletal Muscle Relaxants
- Anticoagulants
- Botulinum Toxin Therapeutics
Treatment
- Surgery
- Medication
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
North America
- the U.S.
- Canada
Europe
- Germany
- France
- the U.K.
- Italy
- Spain
- Rest of Europe
The Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 2017-2023: 7.0% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Diagnosis, Treatment, and End-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Thoracic outlet syndrome market CAGR would be 7% during the forecast period.
North America would dominate the thoracic outlet syndrome market.
The treatment types discussed in the thoracic outlet syndrome market report are medications, physical therapy, surgery, and others.
Europe is the second-largest thoracic outlet syndrome market region.
The players discussed in the thoracic outlet syndrome market are Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Abbott Laboratories, Upsher Smith Laboratories, Inc., Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Daiichi Sankyo, Orient Pharma Co., Ltd., Par Sterile Products, LLC., Mallinckrodt plc., SteriMax Inc., Sanofi, Vertical Pharmaceuticals LLC, and others.
